|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C12N 5/10 | (2006.01) |
| C12N 7/02 | (2006.01) | ||
| C12N 7/04 | (2006.01) | ||
| C12N 15/85 | (2006.01) |
| (11) | Patento numeris | 3489353 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19151187.2 |
| Europos patento paraiškos padavimo data | 2016-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-07-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201520761 | 2015-11-24 | GB | |
| 201609303 | 2016-05-26 | GB |
| (72) |
JOHNSON, Sabine , GB
PALLANT, Celeste , GB
VAMVA, Eirini , GB
VINK, Conrad , GB
|
| (73) |
GlaxoSmithKline Intellectual Property Development
Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
| (54) | STABLE CELL LINES FOR RETROVIRAL PRODUCTION |
| STABLE CELL LINES FOR RETROVIRAL PRODUCTION |